For the year ending 2025-12-31, NUS had $51,747K increase in cash & cash equivalents over the period. $46,009K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | 160,204 |
| Gain on sale of business | 176,162 |
| Depreciation and amortization | 52,261 |
| Non-cash lease expense | 26,227 |
| Stock-based compensation | 24,105 |
| Inventory write-down | 3,807 |
| Foreign currency losses | -6,092 |
| (gain) loss on disposal of assets | -160 |
| Impairment of fixed assets, goodwill and other intangibles | 25,114 |
| Unrealized losses on equity investments | 28,077 |
| Deferred taxes | -20 |
| Accounts receivable, net | -10,055 |
| Inventories, net | -11,887 |
| Prepaid expenses and other | 20,415 |
| Other assets | 8,577 |
| Accounts payable | -9,112 |
| Accrued expenses | -54,315 |
| Other liabilities | 858 |
| Net cash provided by operating activities | 80,286 |
| Purchases of property and equipment | 34,277 |
| Proceeds on investment sales | 10,214 |
| Purchases of investments | 0 |
| Acquisitions (net of cash acquired) | 0 |
| Proceeds from sale of business, net | 193,725 |
| Other, net | -1,000 |
| Net cash provided by (used in) investing activities | 170,662 |
| Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards | -1,912 |
| Payment of cash dividends | 11,834 |
| Repurchase of shares of common stock | 20,040 |
| Finance lease principal payments | 2,238 |
| Contingent consideration payments | 0 |
| Payments on debt | 225,000 |
| Proceeds from debt | 55,000 |
| Other, net | 3,620 |
| Net cash (used in) provided by financing activities | -202,404 |
| Effect of exchange rate changes on cash | 3,203 |
| Net increase (decrease) in cash and cash equivalents | 51,747 |
| Cash and cash equivalents at beginning of period | 186,883 |
| Cash and cash equivalents at end of period | 238,630 |
NU SKIN ENTERPRISES, INC. (NUS)
NU SKIN ENTERPRISES, INC. (NUS)